Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-02-25 @ 8:12 PM
Study NCT ID:
NCT02627859
Status:
UNKNOWN
Last Update Posted:
2016-09-21
First Post:
2015-12-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
26 Week Open Label Study Evaluating Single IA Injection of DUROLANE SJ for Treatment of Osteoarthritis Pain of the Ankle
Sponsor:
Bioventus LLC
Organization:
Study Overview
Official Title:
A 26 Week Multicenter Prospective Open Label Clinical Study Evaluating a Single Intra-articular Injection of DUROLANE SJ1ml for Treatment of OA Pain of the Ankle
Status:
UNKNOWN
Status Verified Date:
2016-09
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
26 week open label study of treatment with Durolane for OA pain of the ankle
Detailed Description:
Single injection Durolane in patients with mild to moderate OA of the ankle.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: